ESMO 2023 Madrid beckons, in just over a week (20th -24th October). Our Research Directors, Lindsay Widger and Siobhan Davies, will be in attendance reporting back on the hottest topics and connecting with like-minded oncology experts to discuss the implications as the results unfold.
The ESMO Congress is a highly influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
Siobhan, Paula and Lindsay have already taken a sneak peek into the abstracts and identified a few hot topics on what lies ahead and what this might mean for the evolving oncology landscape.
Here are our hot topics for ESMO 2023:
- Final curtain for single agent TKIs in 1L EGFR mutant advanced NSCLC?
- Can CheckMate-77T’s glimmer of guidance in the murky realms of resectable NSCLC?
- Shifting sands in 1L mUC management: will a new horizon emerge?
Click here to view our thoughts
Please contact our Oncology Directors to discuss your oncology needs.
Lindsay Widger – l.widger@beyondblueinsight.com
Siobhan Davies – s.davies@beyondblueinsight.com
Paula Coyle – p.coyle@beyondblueinsight.com
Tessa Rothwell – t.rothwell@beyondblueinsight.com